571.73
price down icon0.98%   -5.66
pre-market  Pre-market:  571.73  
loading
Thermo Fisher Scientific Inc. stock is currently priced at $571.73, with a 24-hour trading volume of 1.17M. It has seen a -0.98% decreased in the last 24 hours and a -0.32% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $576.4 pivot point. If it approaches the $566.3 support level, significant changes may occur.
Previous Close:
$577.39
Open:
$577.4
24h Volume:
1.17M
Market Cap:
$218.24B
Revenue:
$42.86B
Net Income/Loss:
$6.00B
P/E Ratio:
37.47
EPS:
15.26
Net Cash Flow:
$6.93B
1W Performance:
+5.58%
1M Performance:
-0.32%
6M Performance:
+31.98%
1Y Performance:
+4.26%
1D Range:
Value
$569.98
$577.99
52W Range:
Value
$415.60
$603.82

Thermo Fisher Scientific Inc. Stock (TMO) Company Profile

Name
Name
Thermo Fisher Scientific Inc.
Name
Phone
781-622-1000
Name
Address
168 Third Avenue, Waltham, MA
Name
Employee
70,000
Name
Twitter
@thermofisher
Name
Next Earnings Date
2024-05-22
Name
Latest SEC Filings
Name
TMO's Discussions on Twitter

Thermo Fisher Scientific Inc. Stock (TMO) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-24-24 Downgrade Barclays Overweight → Equal Weight
Jan-08-24 Downgrade Bernstein Outperform → Mkt Perform
Dec-18-23 Initiated HSBC Securities Buy
Dec-13-23 Initiated Wolfe Research Outperform
Oct-26-23 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Oct-25-23 Upgrade Wells Fargo Underweight → Equal Weight
Sep-28-23 Initiated Bernstein Outperform
Sep-06-23 Resumed Citigroup Buy
Jul-19-23 Initiated Raymond James Outperform
Jul-19-23 Reiterated Robert W. Baird Outperform
Jul-13-23 Upgrade Credit Suisse Neutral → Outperform
Apr-04-23 Reiterated Barclays Overweight
Dec-14-22 Initiated Deutsche Bank Buy
Dec-07-22 Initiated RBC Capital Mkts Outperform
Oct-27-22 Downgrade The Benchmark Company Buy → Hold
Aug-25-22 Initiated Credit Suisse Neutral
Apr-25-22 Downgrade Wells Fargo Equal Weight → Underweight
Jan-26-22 Resumed Barclays Overweight
Oct-20-21 Upgrade Citigroup Neutral → Buy
Oct-15-21 Resumed Cowen Outperform
Aug-05-21 Resumed Credit Suisse Outperform
Jul-16-21 Initiated The Benchmark Company Buy
Mar-18-21 Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Mar-03-21 Initiated Barclays Overweight
Jan-08-21 Upgrade Credit Suisse Neutral → Outperform
Dec-16-20 Downgrade Citigroup Buy → Neutral
Dec-02-20 Initiated Goldman Buy
Nov-10-20 Initiated KeyBanc Capital Markets Sector Weight
Sep-30-20 Initiated Atlantic Equities Overweight
Sep-14-20 Initiated Morgan Stanley Overweight
Aug-20-20 Resumed JP Morgan Overweight
Jul-15-20 Upgrade Cleveland Research Neutral → Buy
Jul-07-20 Reiterated Needham Buy
Apr-23-20 Reiterated Needham Buy
Jan-31-20 Reiterated Needham Buy
Jan-22-20 Initiated Credit Suisse Neutral
Jan-08-20 Initiated Wells Fargo Equal Weight
Jan-07-20 Initiated Citigroup Buy
Nov-15-19 Initiated Stifel Buy
Jul-25-19 Reiterated Needham Buy
Jul-16-19 Downgrade Needham Strong Buy → Buy
May-30-19 Initiated Wolfe Research Outperform
May-23-19 Reiterated Needham Strong Buy
Apr-22-19 Reiterated Needham Strong Buy
Apr-16-19 Reiterated BofA/Merrill Buy
View All

Thermo Fisher Scientific Inc. Stock (TMO) Financials Data

Thermo Fisher Scientific Inc. (TMO) Revenue 2024

TMO reported a revenue (TTM) of $42.86 billion for the quarter ending December 31, 2023, a -4.58% decline year-over-year.
loading

Thermo Fisher Scientific Inc. (TMO) Net Income 2024

TMO net income (TTM) was $6.00 billion for the quarter ending December 31, 2023, a -13.74% decrease year-over-year.
loading

Thermo Fisher Scientific Inc. (TMO) Cash Flow 2024

TMO recorded a free cash flow (TTM) of $6.93 billion for the quarter ending December 31, 2023, a +0.23% increase year-over-year.
loading

Thermo Fisher Scientific Inc. (TMO) Earnings per Share 2024

TMO earnings per share (TTM) was $15.45 for the quarter ending December 31, 2023, a -12.37% decline year-over-year.
loading

Thermo Fisher Scientific Inc. Stock (TMO) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
CASPER MARC N
Chairman & CEO
Mar 13 '24
Option Exercise
190.59
10,000
1,905,900
133,816
CASPER MARC N
Chairman & CEO
Mar 13 '24
Sale
594.58
10,000
5,945,759
123,816
Britt Lisa P.
Sr. VP and Chief HR Officer
Mar 12 '24
Option Exercise
198.85
14,345
2,852,545
25,768
CASPER MARC N
Chairman & CEO
Mar 12 '24
Option Exercise
190.59
10,000
1,905,900
133,816
Britt Lisa P.
Sr. VP and Chief HR Officer
Mar 12 '24
Sale
598.90
14,345
8,591,220
17,323
CASPER MARC N
Chairman & CEO
Mar 12 '24
Sale
597.98
10,000
5,979,758
123,816
CASPER MARC N
Chairman & CEO
Mar 11 '24
Option Exercise
190.59
10,000
1,905,900
135,816
CASPER MARC N
Chairman & CEO
Mar 11 '24
Sale
595.36
10,000
5,953,598
125,816
CASPER MARC N
Chairman & CEO
Feb 29 '24
Option Exercise
190.59
10,000
1,905,900
135,816
CASPER MARC N
Chairman & CEO
Feb 29 '24
Sale
571.08
10,000
5,710,818
125,816
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel products. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. Its Laboratory Products and Services segment offers laboratory refrigerators and freezers, ultralow-temperature freezers and cryopreservation storage tanks, temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis and laboratory equipment; laboratory plastics; laboratory chemicals; research and safety market channel; and pharma services. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.
diagnostics_research DHR
$245.80
price down icon 1.84%
diagnostics_research IQV
$233.98
price down icon 2.85%
$489.24
price down icon 1.02%
diagnostics_research A
$136.37
price down icon 0.81%
diagnostics_research MTD
$1,232.91
price down icon 0.20%
Cap:     |  Volume (24h):